Comprehensive Assessment of Protein and Excipient Stability in Biopharmaceutical Formulations Using H-1 NMR Spectroscopy
| Autor: | Adrian Podmore, Jack E. Bramham, Alexander P. Golovanov, Stephanie A. Davies |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Pharmacology
Drug 1h nmr spectroscopy Chromatography excipients Chemistry media_common.quotation_subject aggregation Excipient Nuclear magnetic resonance spectroscopy Article Biopharmaceutical NMR spectroscopy fragmentation medicine biopharmaceutical formulation Pharmacology (medical) medicine.drug media_common |
| Zdroj: | Bramham, J E, Podmore, A, Davies, S A & Golovanov, A P 2021, ' Comprehensive Assessment of Protein and Excipient Stability in Biopharmaceutical Formulations Using H-1 NMR Spectroscopy ', ACS Pharmacology & Translational Science, vol. 4, no. 1, pp. 288-295 . https://doi.org/10.1021/acsptsci.0c00188 ACS Pharmacology & Translational Science |
| DOI: | 10.1021/acsptsci.0c00188 |
| Popis: | Biopharmaceutical proteins are important drug therapies in the treatment of a range of diseases. Proteins, such as antibodies (Abs) and peptides, are prone to chemical and physical degradation, particularly at the high concentrations currently sought for subcutaneous injections, and so formulation conditions, including buffers and excipients, must be optimized to minimize such instabilities. Therefore, both the protein and small molecule content of biopharmaceutical formulations and their stability are critical to a treatment's success. However, assessing all aspects of protein and small molecule stability currently requires a large number of analytical techniques, most of which involve sample dilution or other manipulations which may themselves distort sample behavior. Here, we demonstrate the application of 1H nuclear magnetic resonance (NMR) spectroscopy to study both protein and small molecule content and stability in situ in high-concentration (100 mg/mL) Ab formulations. We show that protein degradation (aggregation or fragmentation) can be detected as changes in 1D 1H NMR signal intensity, while apparent relaxation rates are specifically sensitive to Ab fragmentation. Simultaneously, relaxation-filtered spectra reveal the presence and degradation of small molecule components such as excipients, as well as changes in general solution properties, such as pH. 1H NMR spectroscopy can thus provide a holistic overview of biopharmaceutical formulation content and stability, providing a preliminary characterization of degradation and acting as a triaging step to guide further analytical techniques. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|